Direkt zum Inhalt
Bannergrafik (FB20)
Sie sind hier:» Universität » Medizin » Klinik für Nuklearmedizin » Publikationen
  • Print this page
  • create PDF file



Publikationen im Jahr 2014

Weber T, Luster M.
[Localization of parathyroid adenomas with C11-methionine PET-CT.]
Chirurg. 2014 Mar 7. [Epub ahead of print] German.

Verburg FA, Heinzel A, Hänscheid H, Mottaghy FM, Luster M, Giovanella L.
Nothing new under the nuclear sun: towards 80 years of theranostics in nuclear medicine.
Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):199-201. doi: 10.1007/s00259-013-2609-2. Epub 2013 Nov 6. No abstract available.

Krug S, König A, Librizzi D, Nimphius W, Gress TM, Michl P, Rinke A. Internist (Berl).
[A 59-year-old patient with recurrent flushes and bland hepatic cyst].
2014 Feb;55(2):206-11. doi: 10.1007/s00108-013-3433-2. German.

Van Hoorn RA, Vriens D, Postema JW, Arens AI, Pfestroff A, Oyen WJ, Gotthardt M.
The influence of SPECT reconstruction algorithms on image quality and diagnostic accuracy in phantom measurements and 99mTc-sestamibi parathyroid scintigraphy.
Nucl Med Commun. 2014 Jan;35(1):64-72. doi: 10.1097/MNM.0000000000000020.

Mandapathil M, Teymoortash A, Heinis J, Wiegand S, Güldner C, Hoch S, Roeßler M, Werner JA.
Freehand SPECT for sentinel lymph node detection in patients with head and neck cancer: first experiences.
Acta Otolaryngol. 2014 Jan;134(1):100-4. doi: 10.3109/00016489.2013.832376. Epub 2013 Nov 21.

Publikationen im Jahr 2013

Turowska A, Librizzi D, Baumgartl N, Kuhlmann J, Dicke T, Merkel O, Homburg U, Höffken H, Renz H, Garn H.
Biodistribution of the GATA-3-specific DNAzyme hgd40 after inhalative exposure in mice, rats and dogs.
Toxicol Appl Pharmacol. 2013 Oct 15;272(2):365-72. doi: 10.1016/j.taap.2013.06.020. Epub 2013 Jun 29

Kletting P, Schimmel S, Kestler HA, Hänscheid H, Luster M, Fernández M, Bröer JH, Nosske D, Lassmann M, Glatting G.
Molecular radiotherapy: the NUKFIT software for calculating the time-integrated activity coefficient.
Med Phys. 2013 Oct;40(10):102504. doi: 10.1118/1.4820367.

Verburg FA, Luster M, Cupini C, Chiovato L, Duntas L, Elisei R, Feldt-Rasmussen U, Rimmele H, Seregni E, Smit JW, Theimer C, Giovanella L.
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
Thyroid. 2013 Oct;23(10):1211-25. doi: 10.1089/thy.2012.0606. Epub 2013 Aug 3.

Banach R, Bartès B, Farnell K, Rimmele H, Shey J, Singer S, Verburg FA, Luster M.
Results of the Thyroid Cancer Alliance international patient/survivor survey: Psychosocial/informational support needs, treatment side effects and international differences in care.
Hormones (Athens). 2013 Jul-Sep;12(3):428-38.

Weber T, von Baer A, Schultheiß M, Maier-Funk C, Luster M, Barth TF, Boehm BO.
Cystic lesions with suspected soft tissue infiltration.
JAMA Surg. 2013 Jul;148(7):691-2. doi: 10.1001/jamasurg.2013.307. No abstract available.

Hänscheid H, Canzi C, Eschner W, Flux G, Luster M, Strigari L, Lassmann M.
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry II. Dosimetry prior to radioiodine therapy of benign thyroid diseases.
Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1126-34. doi: 10.1007/s00259-013-2387-x. Epub 2013 Apr 11.

Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF, Henne-Bruns D, Boehm BO, Reske SN, Luster M.
Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT.
Ann Surg. 2013 Jun;257(6):1124-8. doi: 10.1097/SLA.0b013e318289b345.

Pitoia F, Bueno MF, Abelleira E, Salvai ME, Bergoglio L, Luster M, Niepomniszcze H.
Undetectable pre-ablation thyroglobulin levels in patients with differentiated thyroid cancer: it is not always what it seems.
Arq Bras Endocrinol Metabol. 2013 Jun;57(4):300-6.

Veit JA, Boehm B, Luster M, Scheuerle A, Rotter N, Rettinger G, Scheithauer M.
Detection of paranasal ectopic adrenocorticotropic hormone-secreting pituitary adenoma by Ga-68-DOTANOC positron-emission tomography-computed tomography.
Laryngoscope. 2013 May;123(5):1132-5. doi: 10.1002/lary.23867. Epub 2013 Jan 8.

Verburg FA, Reiners C, Grelle I, Barth H, Fassnacht M, Luster M.
Calcium stimulated calcitonin measurement: a procedural proposal.
Exp Clin Endocrinol Diabetes. 2013 May;121(5):318-20. doi: 10.1055/s-0033-1333686. Epub 2013 Feb 21. Review.

Hundt W, Schink C, Steinbach S, O'Connell-Rodwell CE, Burbelko M, Kiessling A, Librizzi D, Pfestroff A, Guccione S.
Imaging of firefly luciferase activity under antiangiogenic therapy in a heat shock protein 70-transfected melanoma tumor model.
Mol Imaging. 2013 Mar-Apr;12(2):129-36.

Luster M, Musholt TJ.
Thyroid gland: thyroid surgery and radioiodine ablation-the surgeon's role.
Nat Rev Endocrinol. 2013 Mar;9(3):140-1. doi: 10.1038/nrendo.2012.229. Epub 2012 Nov 27. No abstract available.

Dralle H, Musholt TJ, Schabram J, Steinmüller T, Frilling A, Simon D, Goretzki PE, Niederle B, Scheuba C, Clerici T, Hermann M, Kußmann J, Lorenz K, Nies C, Schabram P, Trupka A, Zielke A, Karges W, Luster M, Schmid KW, Vordermark D, Schmoll HJ, Mühlenberg R, Schober O, Rimmele H, Machens A.
German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors German Societies of General and Visceral Surgery; Endocrinology; Nuclear Medicine; Pathology; Radiooncology; Oncological Hematology; and the German Thyroid Cancer Patient Support Organization Ohne Schilddrüse leben e.V.
Langenbecks Arch Surg. 2013 Mar;398(3):347-75. doi: 10.1007/s00423-013-1057-6. Epub 2013 Mar 3. Review.

Krug S, Portig I, Librizzi D, Pfestroff A, Gress T, Michl P.
[A 79-year-old man with B symptoms and jaw claudication].
Internist (Berl). 2013 Feb;54(2):249-53. doi: 10.1007/s00108-012-3223-2. German.

Verburg FA, Mäder U, Tanase K, Thies ED, Diessl S, Buck AK, Luster M, Reiners C.
J Clin Endocrinol Metab: Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients.
2013 Jan;98(1):172-80. doi: 10.1210/jc.2012-2458. Epub 2012 Nov 12

Kletting P, Schimmel S, Kestler HA, Hänscheid H, Luster M, Fernández M, Bröer JH, Nosske D, Lassmann M, Glatting G.
Erratum: "Molecular radiotherapy: The NUKFIT software for calculating the time-integrated activity coefficient"
[Med. Phys. 40, 102504 (2013)].

Verburg F, Weber T, Luster M.
¹³¹I sodium-iodide versus 56Fe surgical steel. Which is better for lateral lymph node metastases in differentiated thyroid cancer patients?
Nuklearmedizin. 2013;52(4):113-4.

Publikationen im Jahr 2012

Chiesa C, Luster M, Lassmann M.
4th international symposium on targeted radiotherapy and dosimetry (ISTARD): best ranked abstract publication.
Q J Nucl Med Mol Imaging. 2012 Dec;56(6):485-6.

Weber T, Ohlhauser D, Hillenbrand A, Henne-Bruns D, Reske SN, Luster M.
Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Horm Metab Res. 2012 Nov;44(12):904-8. doi: 10.1055/s-0032-1316351. Epub 2012 Jul 12.

Verburg FA, Dietlein M, Freudenberg L, Leboulleux S, Pitoia F, Reiners C, Stokkel M, Luster M.
Recombinant human TSH versus thyroid hormone withdrawal.
J Nucl Med. 2012 Nov;53(11):1815-6; author reply 1816-1817. doi: 10.2967/jnumed.112.108738. Epub 2012 Aug 30.

Krug S, Bartsch DK, Schober M, Librizzi D, Pfestroff A, Burbelko M, Moll R, Michl P, Gress TM
Successful selective internal radiotherapy (SIRT) in a patient with a malignant solid pseudopapillary pancreatic neoplasm (SPN).
Pancreatology. 2012 Sep-Oct;12(5):423-7. doi: 10.1016/j.pan.2012.07.014. Epub 2012 Jul 21.

Zheng M, Librizzi D, Kılıç A, Liu Y, Renz H, Merkel OM, Kissel T.
Enhancing in vivo circulation and siRNA delivery with biodegradable polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol) copolymers.
Pancreatology. 2012 Sep;33(27):6551-8. doi: 10.1016/j.biomaterials.2012.05.055. Epub 2012 Jun 16.

Sohrabi K, Sohrabi A, Librizzi D, Mursina L, Koehler U, Gross V.
Nasal long-term inhalation facilitates enhanced thoracic particle deposition.
Biomed Tech (Berl). 2012 Sep 6. pii: /j/bmte.2012.57.issue-s1-Q/bmt-2012-4224/bmt-2012-4224.xml. doi: 10.1515/bmt-2012-4224.

Weber T, Ohlhauser D, Hillenbrand A, Henne-Bruns D, Reske SN, Luster M./>Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Horm Metab Res. 2012 Jul 12. [Epub ahead of print]. Impact factor:2.7.

Renette T, Librizzi D, Endres T, Merkel O, Beck-Broichsitter M, Bege N, Petersen H, Curdy C, Kissel T.
Poly(ethylene carbonate) nanoparticles as carrier system for chemotherapy showing prolonged in vivo circulation and anti-tumor efficacy.
Pancreatology. Macromol Biosci. 2012 Jul;12(7):970-8. doi: 10.1002/mabi.201100499. Epub 2012 May 30.

Olbert PJ, Heinis J, Hofmann R, Hegele A.
Choline PET/CT in the diagnosis of primary and recurrent prostate cancer. Are there evidence-based indications?].
Urologe A. 2012 Jun;51(6):843-7. doi: 10.1007/s00120-012-2830-9. Review. German

Hundt W, Schink C, Steinbach S, O'Connell-Rodwell CE, Kiessling A, Librizzi D, Burbelko M, Guccione S.
Effect of antiangiogenic therapy on luciferase activity in a cytomegalovirus- or HSP70-promoter-transfected M21 tumor model.
J Biomed Opt. 2012 Jun;17(6):065001. doi: 10.1117/1.JBO.17.6.065001.

Reiners C, Luster M .
Radiotherapy: radioiodine in thyroid cancer-how to minimize side effects.
Nat Rev Clin Oncol. 2012 Jun 19;9(8):432-4. doi: 10.1038/nrclinonc.2012.101. No abstract available.

Weber T, von Baer A, Schultheiss M, Maier Funk C, Luster M, Barth TFE, Bernhard O Boehm BO.
Primary hyperparathyroidisn with multiple brown tumors (Image of the Month).
Archives of Surgery. 2012 (accepted). Impact factor: 4,5

Weber T, Elser H, Luster M.
Möglichkeiten der Lokalisationsdiagnostik beim primären Hyperparathyreoidismus.
Internistische Praxis. 2012 (accepted).

Luster M, Hänscheid H, Freudenberg LS, Verburg FA.
Radioiodine therapy of metastatic lesions of Differentiated Thyroid Cancer.
Jornal of Endocrinological Investigation. 2012; 35 (Suppl.): 21-29. Impact factor: 1.5

Reiners C, Lassmann M, Luster M.
Recombinant TSH and Differertiated Thyroid Cancer: 10 Years of Clinical Application. Safty and Quality Life.
Journal of Endocrinological Investigation. 2012; 35 (Suppl.): 30-35. Impact factor: 1.5

Kotzerk J, Luster M, Freesmeyer M.
Gebt mir einen festen Punkt im All, und ich hebe die Welt aus den Angeln.
Nuklearmedizin.2012;51:65-66. Impact factor: 1.9

Luster M, Reiners C.
Algorithmen für die Nachsorge des Schilddrüsenkarzinoms- Algorithms for Follow-up of Thyroid Cancer.
Nuklearmedizin. 2012; 35: 1-5.

Pacini F, Ito Y, Luster M, Pitoia F, Robinson B, Wirth L.
Radioactive Iodine refractory Differentiated Thyroid Cancer: Unmet Needs and Future Directions. Expert Rewiew of Endocrinology and Metabolism.
2012 accepted.

Karakas E, Kann S, Höffken H, Bartsch DK, Celik I, Görg C, Pfestroff A.
Does contrast-enhanced cervical ultrasonography improve preoperative localization results in patients with sporadic primary hyperparathyroidism?
J Clin Imaging Sci. 2012;2:64. doi: 10.4103/2156-7514.103054. Epub 2012 Oct 31.

Gratz S, Reize P, Pfestroff A, Höffken H.
Intact versus fragmented 99mTc-monoclonal antibody imaging of infection in patients with septically loosened total knee arthroplasty.
J Int Med Res. 2012; 40(4):1335-42.

Reiners C, Lassmann M, Luster M.
Recombinant human thyrotropin: safety and quality of life evaluation.
J Endocrinol Invest. 2012;35(6 Suppl):30-5. Review.

Luster M, Hänscheid H, Freudenberg LS, Verburg FA.
Radioiodine therapy of metastatic lesions of differentiated thyroid cancer.
J Endocrinol Invest. 2012;35(6 Suppl):21-9. Review.

Kotzerke J, Luster M, Freesmeyer M.
[Give me a fixed point in space, and I will lift the world upside down].
Nuklearmedizin. 2012;51(3):65-6. doi: 10.3413/nukmed-2012030001. German.

Publikationen im Jahr 2011

Gratz S, Kaiser, Höffken H
Diagnostic imaging in patients with coronary artery disease: the nuclear medicine physicians' view.
Dtsch Med Wochenschr. 2011 Oct;136(41):2094-9. doi: 10.1055/s-0031-1292019. Epub 2011 Oct 4. Review. German.

Merkel OM, Zheng M, Mintzer MA, Pavan GM, Librizzi D, Maly M, Höffken H, Danani A, Simanek EE, Kissel T.
Molecular modeling and in vivo imaging can indentify successful flexible trianzine dendrimer-based siRNA delivery systems.
J Control Release. 2011 Jul 15;153(1):23-33. Epub 2011 Feb 20.

Publikationen im Jahr 2010

Pfestroff A, Müller F, Librizzi D, Eivanzi B, Béhé M, Höffken H, Behr TM, Teymoortash A.
Scintigraphic assessment of salivary gland function in a rat model.
In Vivo. 2010 Sep-Oct;24(5):681-5.

Merkel OM, Mintzer MA, Librizzi D, Samsonova O, Dicke T, Sproat B, Garn PJ, Simanek EE, Kissel T.
Trianzine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.
Mol Pharm. 2010 Aug 2;7(4):969-83.

Gratz S, Kemke B, Kaiser W, Heinis J, Behr TM, Höffken.
Incidental non-secreting adrenal masses in cacer patients: intra-individual comparison  of 18F-fluorodeoxyglucose positron emission tomography with computed tomography and shift magnetic resonance imaging.
J Int Med Res. 2010 Mar-Apr;38(2):633-44.

Publikationen im Jahr 2009

Riese CG, Seitz S, Schipper ML, Behr TM.
Effective treatment of pancreatic neuroendocrine tumors transfected with the sodium iodide symporter gene by 186Re-perrhenate in mice.
Eur J Nucl Med Mol Imaging. 2009 Nov;36(11):1767-73. Epub 2009 May 16.

Gratz S, Kemke B, Kaiser W, Hahn U, Erdtmann B, Schilling M, Schneider B, Behr TM.
Diagnosis of fever of unknown origin (FUO). Positron emission tomography/computed tomography (PET/CT).
Dtsch Med Wochenschr. 2009 Oct;134(42):2120-4. Epub 2009 Oct 6. Review. German.

Merkel OM, Librizzi D, Pfestroff A, Schurrat T, Buyens K, Sanders NN, De Smedt SC, Béhé M, Kissel T.
Stability of siRNA polyplexes from poly(ethylenimine) and poly(ethyleniminie)-g-poly(ethylene glycol) under in vivo conditions: effects on pharmacokinetics and biodistribution measured by Fluorescence Fluctuation Spectroscopy and Single Photon Emission Computed Tomography (SPECT) imaging.
J Controll Release. 2009 Sep 1;138(2):148-59. Epub 2009 May 19.

Teymoortash A, Müller F, Juricko J, Bieker M, Mandic R, Librizzi D, Höffken H, Pfestroff A, Werner JA.
Botulinum toxin prevents radiotherapy-included salivary gland damage.
Oral Oncol. 2009 Aug;45(8):737-9. Epub 2009 Feb 11.

Merkel OM, Beyerle A, Librizzi D, Pfestroff A, Behr TM, Sproat B, Barth PJ, Kissel T.
Nonviral siNRA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance.
Mol Pharm.2009 Jul-Aug;6(4):1246-60.

Kalinowsky M, Dressler M, König A, El-Sheik M, Rinke A, Höffken H, Gress TM, Arnold R, Klose KJ, Wagner HJ.
Selective internal radiotherapy with Yttrium-90 microsheres for hepatic metastatic neuroendocrine tumors: a prospective single center study.
Digestion. 2009;79(3):137-42. Epub 2009 Mar 23.

Marshall VL, Reiniger CB, Marquardt M, Patterson J, Hadley DM, Oertel WH, Benamer HT, Kemp P, Burn D, Tolosa E, Kulisevsky J, Cunha L, Costa D, Booij J, Tatsch K, Chaudhuri KR, Ulm G, Pogarell O, Höffken H, Gerstner A, Grosset DG.
Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: a 3-year European multicenter study with repeat [123I]FP-CIT SPECT.
Mov Disord. 2009 Mar 15;24(4):500-8.

Gratz S, Behr TM, Reize P, Pfestroff A, Kampen WU, Höffken H.
(99m)Tc-Fab' fragments (sulesomab) for imaging septically loosened total knee arthroplasty.
J Int Med Res. 2009 Jan-Feb;37(1):54-67.

Merkel OM, Librizzi D, Pfestroff A, Schurrat T, Béhé M, Kissel T.
In vivo SPECT and real-time gamma camera imaging of biodistribution and pharmacokinetics of siRNA delivery unsing an optimized radiolabeling and purification procedure.
Bioconjug Chem. 2009 Jan;20(1):174-82

Gratz S, Höffken H, Kaiser JW, Behr TM, Strosche H, Reize P.
Nuclear medical imaging in case of painful knee arthroplasty.
Radiologie. 2009 Jan;49(1):59-67. German.

Publikationen im Jahr 2008

Gratz S, Kempke B, Kaiser W, Behr TM, Pfestroff A, Höffken H.
Unexpected 99mTc-tetrofosmin findings during myocardial perfusion scintigraphy: intraindividual comparison with PET/computed tomography.
Nucl Med Commun. 2008 Nov;29(11):963-9.

Librizzi D, Mazzola E, Maragliano S, Macaluso A, Matranga S, Di Miceli G.
[The descending necrotizing mediastinitis].
G Chir. 2008 Aug-Sep;29(8-9):347-50. Italian

Publikationen im Jahr 2007

Alvarez-Fischer D, Blessmann G, Trosowski C, Béhé M, Schurrat T, Hartmann A, Behr TM, Oertel WH, Höglinger GU, Höffken H.
Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.
Neuroimage. 2007 Oct 15;38(1):5-12. Epub 2007 Jun 14.

Romano A, Scarlata F, Giordano S, Infurnari L, Li Vecchi V, Librizzi D, D'Angelo M, Lipani G, Marasa L.
[Two cases of actinomycosis].
Infez Med. 2007 Sep;15(3):191-4.Italian.

Kalinowski M, Goldmann K, Gotthard M, Rössler M, Pfestroff A, Klose KJ, Wagner HJ.
Effectiveness and renal tolerance of multidetector helical CT with gadobutrol: result of a comparative porcine study.
Radiology. 2007 Aug;244(2):457-63. Epub 2007 Jun 11.

Neu M, Germershaus O, Mao S, Voigt KH, Behe M, Kissel T.
Crosslinked nanocarriers based upon poly(ethylene imine) for systemic plasmid delivery: In vitro characterization and in vivo studies in mice.
J Control Release. 2007 Apr 23;118(3):370-80. Epub 2007 Jan 20.

Gotthardt M, van Eerd-Vismale J, Oyen WJ, de Jong M, Zhang H, Rolleman E, Maecke HR, Behe M, Boerman O.
Indication for Different Mechanisms of Kidney Uptake of Radiolabeled Peptides.
J Nucl Med. 2007 Apr;48(4):596-601.

Tackenberg B, Metz A, Unger M, Schimke N, Passow S, Hoeffken H, Hoffmann GF, Muller U, Nolte D, Oertel WH, Eggert K, Moller JC.
Nigrostriatal dysfunction in X-linked dystonia-parkinsonism (DYT3).
Mov Disord. 2007 Mar 20; [Epub ahead of print] No abstract available.

Béhé M, Gotthard M, Behr TM.
Imaging of gastrinomas by nuclear medicine methods.
Wien Klin Wochenschr. 2007;119(19-20)593-6. Review.

Gotthard M, Bröker S, Schliek A, Bauhofer A, Herbst B, Béhé M, Cortens FH, Behr TM, Görg C.
Scintigraphy with 99mTc-labled heat-altered erythrocytes in diagnosing hyposplenia: prospective comparison to 99mTc-labled colloids and colour-duplex ultrasonography.
Nuklearmedizin. 2007;46(4):135-40

Publikationen im Jahr 2006

Gotthardt M, Lalyko G, van Eerd-Vismale J, Keil B, Schurrat T, Hower M, Laverman P, Behr TM, Boerman OC, Goke B, Behe M.
A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents.
Regul Pept. 2006 Dec 10;137(3):162-7. Epub 2006 Aug 22.

Schipper ML, Riese CG, Seitz S, Weber A, Behe M, Schurrat T, Schramm N, Keil B, Alfke H, Behr TM.
Efficacy of (99m)Tc pertechnetate and (131)I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo.
Eur J Nucl Med Mol Imaging. 2006 Dec 8; [Epub ahead of print]

Gotthardt M, Behe MP, Grass J, Bauhofer A, Rinke A, Schipper ML, Kalinowski M, Arnold R, Oyen WJ, Behr TM.
Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours.
Endocr Relat Cancer. 2006 Dec;13(4):1203-11.

Wild D, Behe M, Wicki A, Storch D, Waser B, Gotthardt M, Keil B, Christofori G, Reubi JC, Macke HR.
[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
J Nucl Med. 2006 Dec;47(12):2025-33.

Gotthardt M, Behe MP, Beuter D, Battmann A, Bauhofer A, Schurrat T, Schipper M, Pollum H, Oyen WJ, Behr TM.
Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma.
Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1273-9. Epub 2006 Jul 11.

Germershaus O, Merdan T, Bakowsky U, Behe M, Kissel T.
Trastuzumab-polyethylenimine-polyethylene glycol conjugates for targeting Her2-expressing tumors.
Bioconjug Chem. 2006 Sep-Oct;17(5):1190-9.

Stork S, Behr TM, Birk M, Uberfuhr P, Klauss V, Spes CH, Angermann CE.
Assessment of cardiac allograft vasculopathy late after heart transplantation: when is coronary angiography necessary?
J Heart Lung Transplant. 2006 Sep;25(9):1103-8.

Kim HC, Hartner S, Behe M, Behr TM, Hampp NA.
Two-photon absorption-controlled multidose drug release: a novel approach for secondary cataract treatment.
J Biomed Opt. 2006 May-Jun;11(3):34024.

Gotthardt M, Siegert MJ, Schlieck A, Schneider S, Kohnert A, Gross MW, Schafer C, Wagner R, Hormann S, Behr TM, Engenhart-Cabillic R, Klose KJ, Jungclas H, Glowalla U.
How to successfully implement E-learning for both students and teachers.
Acad Radiol. 2006 Mar;13(3):379-90.

Gotthardt M, Rubner C, Bauhofer A, Berce F, Oyen WJ, Goecke J, Pfestroff A, Schlieck A, Corstens FH, Behe M, Behr TM.
What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?
Nuklearmedizin. 2006;45(5):206-12.

Gotthardt M, Stubinger M, Pansegrau J, Buchwald B, Goecke J, Pfestroff A, Corstens FH, Behr TM.
Decrease of (99m)Tc-uptake in autonomous thyroid tissue in Germany since the 1970s. Clinical implications for radioiodine therapy.
Nuklearmedizin. 2006;45(3):122-5.

Publikationen im Jahr 2005

Eicke N, Gunthert AR, Viereck V, Siebold D, Behe M, Becker T, Emons G, Grundker C.
GnRH-II receptor-like antigenicity in human placenta and in cancers of the human reproductive organs.
Eur J Endocrinol. 2005 Oct;153(4):605-12.

Nock BA, Maina T, Behe M, Nikolopoulou A, Gotthardt M, Schmitt JS, Behr TM, Macke HR.
CCK-2/gastrin receptor-targeted tumor imaging with (99m)Tc-labeled minigastrin analogs.
J Nucl Med. 2005 Oct;46(10):1727-36.

Liersch T, Meller J, Kulle B, Behr TM, Markus P, Langer C, Ghadimi BM, Wegener WA, Kovacs J, Horak ID, Becker H, Goldenberg DM.
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.
J Clin Oncol. 2005 Sep 20;23(27):6763-70.

Storch D, Behe M, Walter MA, Chen J, Powell P, Mikolajczak R, Macke HR.
Evaluation of [99mTc/EDDA/HYNIC0]octreotide derivatives compared with [111In-DOTA0,Tyr3, Thr8]octreotide and [111In-DTPA0]octreotide: does tumor or pancreas uptake correlate with the rate of internalization?
J Nucl Med. 2005 Sep;46(9):1561-9.

Behe M, Kluge G, Becker W, Gotthardt M, Behr TM.

Use of polyglutamic acids to reduce uptake of radiometal-labeled minigastrin in the kidneys.
J Nucl Med. 2005 Jun;46(6):1012-5.

Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G.
Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.
Brain. 2005 Jan;128(Pt 1):126-37.

Schurrat T, Schulz C, Béhé M, Schramm NU, Engeland U, Ebel G, Behr TM
Vortrag und paper: Influence of the clinically most important radionuclides on sensitivity and spatial resolution of a high resolution multiple pinhole SPECT for small animal imaging
Biomedizinische Technik, Vol. 50, Suppl. Vol. 1, Part 2: 889-890, 2005

Schurrat T, Schramm NU, Ebel G, Alfke H, Nock B, Maina T, Maecke H, Behr TM, Béhé M
Vortrag und paper: Molecular imaging of living mice using high resolution multiple pinhole SPECT and image fusion with anatomical MRI studies
Biomedizinische Technik, Vol. 50, Suppl. Vol. 1, Part 2: 901-902, 2005

Publikationen im Jahr 2004

Behr TM, Willette RN, Coatney RW, Berova M, Angermann CE, Anderson K, Sackner-Bernstein JD, Barone FC.
Eprosartan improves cardiac performance, reduces cardiac hypertrophy and mortality and downregulates myocardial monocyte chemoattractant protein-1 and inflammation in hypertensive heart disease.
J Hypertens. 2004 Mar;22(3):583-92.

Ehrenreich H, Degner D, Meller J, Brines M, Behe M, Hasselblatt M, Woldt H, Falkai P, Knerlich F, Jacob S, von Ahsen N, Maier W, Bruck W, Ruther E, Cerami A, Becker W, Siren AL.
Erythropoietin: a candidate compound for neuroprotection in schizophrenia.
Mol Psychiatry. 2004 Jan;9(1):42-54.

Fischer M, Behr T, Grunwald F, Knapp WH, Trumper L, von Schilling C; German Society for Hematology and Oncology.
[Guideline for radioimmunotherapy of rituximab relapsed or refractory CD20(+) follicular B-cell non-Hodgkin's lymphoma]
Nuklearmedizin. 2004 Oct;43(5):171-6.

Gotthardt M, Battmann A, Hoffken H, Schurrat T, Pollum H, Beuter D, Gratz S, Behe M, Bauhofer A, Klose KJ, Behr TM.
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature.
Nucl Med Commun. 2004 May;25(5):439-43.

Gotthardt M, Boermann OC, Behr TM, Behe MP, Oyen WJ.
Development and clinical application of peptide-based radiopharmaceuticals.
Curr Pharm Des. 2004;10(24):2951-63.

Gotthardt M, Lohmann B, Behr TM, Bauhofer A, Franzius C, Schipper ML, Wagner M, Hoffken H, Sitter H, Rothmund M, Joseph K, Nies C.
Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature.
World J Surg. 2004 Jan;28(1):100-7.

Gratz S, Barth P, Arnold R, Behr TM.
Graves' disease with unilateral radioisotope uptake.
Nuklearmedizin. 2004 Oct;43(5):N66-8.

Kann PH, Wirkus B, Behr T, Klose KJ, Meyer S.
Endosonographic imaging of benign and malignant pheochromocytomas.
J Clin Endocrinol Metab. 2004 Apr;89(4):1694-7.

Knake S, Haag A, Pilgramm G, Reis J, Klein KM, Hoeffken H, Bartenstein P, Oertel WH, Hamer HM, Rosenow F.
Ictal functional TCD for the lateralization of the seizure onset zone-a reportof two cases.
Epilepsy Res. 2004 Nov;62(1):89-93.

Laverman P, Behe M, Oyen WJ, Willems PH, Corstens FH, Behr TM, Boerman OC.
Two technetium-99m-labeled cholecystokinin-8 (CCK8) peptides for scintigraphic imaging of CCK receptors.
Bioconjug Chem. 2004 May-Jun;15(3):561-8.

von Guggenberg E, Behe M, Behr TM, Saurer M, Seppi T, Decristoforo C.
99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
Bioconjug Chem. 2004 Jul-Aug;15(4):864-71.

Werner JA, Dunne AA, Folz BJ, Moll R, Behr T.
Value of sentinel lymphadenectomy in head and neck cancer.
Ann Surg Oncol. 2004 Mar;11(3 Suppl):267S-70S.

Werner JA, Dunne AA, Ramaswamy A, Dalchow C, Behr T, Moll R, Folz BJ, Davis RK.
The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck?
Head Neck. 2004 Jul;26(7):603-11.

Werner JA, Sapundzhiev NR, Teymoortash A, Dunne AA, Behr T, Folz BJ.
Endoscopic sentinel lymphadenectomy as a new diagnostic approach in the N0 neck.
Eur Arch Otorhinolaryngol. 2004 Oct;261(9):463-8.

Zaplatnikov K, Menzel C, Dobert N, Hamscho N, Kranert WT, Gotthard M, Behr TM, Grunwald F.
Case report: drug interference with MIBG uptake in a patient with metastatic paraganglioma.
Br J Radiol. 2004 Jun;77(918):525-7.

Publikationen im Jahr 2003

Dodel RC, Hoffken H, Moller JC, Bornschein B, Klockgether T, Behr T, Oertel WH, Siebert U.
Dopamine transporter imaging and SPECT in diagnostic work-up of Parkinson's disease: a decision-analytic approach.
Mov Disord. 2003 Oct;18 Suppl 7:S52-62.

Gotthardt M, Behe MP, Alfke H, Behr TM.
Imaging lung tumors with peptide-based radioligands.
Clin Lung Cancer. 2003 Sep;5(2):119-24.

Oertel WH, Gerstner A, Hoffken H, Dodel RC, Eggert KM, Moller JC.
Role of dopamine transporter SPECT for the practitioner and the general neurologist.
Mov Disord. 2003 Oct;18 Suppl 7:S9-15.

Muscolino G, Librizzi D.
[Clinical results in lung cancer patients undergoing a bronchoplastic surgical procedure].
Tumori. 2003 Jul-Aug;89(4 Suppl):271. Italian. No abstract available.

Schramm NU, Ebel G, Engeland U, Schurrat T, Behe M, Behr TM
High-resolution SPECT using multipinhole collimation
Ieee Transactions On Nuclear Science 50 (3): 315-320 Part 2 JUN 2003

Maragliano S, Di Miceli G, Librizzi D, Muscolino G.
Tuberous sclerosis with pulmonary involvement. A rare cause of bilateral pneumothorax. A case report.
Chir Ital. 2003 May-Jun;55(3):465-8.

Schurrat T, Alfke H, Behe M, Maina T, Nock B, Mäcke H, Heverhagen JT, Klose KJ, Halling H, Behr TM, Schramm N

Molecular gastrin receptor localisation in mice using high-resolution SPET-MRI image fusion
Eur J Nucl Med. and Molecular Imaging Vol. 30, No. 3, S. 800, March 2003

Publikationen im Jahr 2002

Arnold R, Wied M, Behr T.
Somatostatin analogues in the treatment of endocrine tumours of the gastrointestinal tract.
Expert Opin Pharmacother. 2002 Jan;3(1):643-656.

Behr TM, Behe M, Kluge G, Gotthardt M, Schipper ML, Gratz S, Arnold R, Becker W, Goldenberg DM.
Nephrotoxicity versus anti-tumour efficacy in radiopeptide therapy: facts and myths about the Scylla and Charybdis.
Eur J Nucl Med. 2002;29(2):277-9.

Behr TM, Behe MP.
Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
Semin Nucl Med. 2002 Apr;32(2):97-109.

Behr TM, Gotthardt M, Becker W, Behe M.
Radioiodination of monoclonal antibodies, proteins and peptides for diagnosis and therapy. A review of standardized, reliable and safe procedures for clinical grade levels kBq to GBq in the Gottingen/Marburg experience.
Nuklearmedizin. 2002 Apr;41(2):71-9.

Behr TM, Griesinger F, Riggert J, Gratz S, Behe M, Kaufmann CC, Wormann B, Brittinger G, Becker W.
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study.
Cancer. 2002;94(4 Suppl):1363-72.

Behr TM, Liersch T, Greiner-Bechert L, Griesinger F, Béhé M, Markus PM, Gratz S, Angerstein C, Brittinger G, Becker H, Goldenberg DM, Becker W.
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.
Cancer. 2002;94(4 Suppl):1373-81.

Schramm NU, Engeland U, Ebel G, Schurrat T, Béhé M, Behr TM
Multi-pinhole SPECT for small animal research
Journal Of Nuclear Medicine 43 (5): 913 Suppl. S May 2002

Gotthardt M, Schipper ML, Behe M, Hoeffken H, Gratz S, Pollum H, Schurrat T, Djomotschko J, Schlieck A, Goecke K, Behr TM
In-111-DTPA-D-GLu(1)-minigastrin used for diagnosis of medullary thyroid carcinoma in comparison to F-18-FDG PET and CT scanning
Journal Of Nuclear Medicine 43 (5): 467 Suppl. S May 2002

Gotthardt M, Fischer M, Naeher I, Holz JB, Jungclas H, Fritsch HW, Behe M, Goke B, Joseph K, Behr TM.
Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results.
Eur J Nucl Med. 2002 May;29(5):597-606.

Gotthardt M, Schipper M, Franzius C, Behe M, Barth A, Schurrat T, Hoeffken H, Gratz S, Joseph K, Behr TM.
Follow-up of perfusion defects in pulmonary perfusion scanning after pulmonary embolism: are we too careless?
Nucl Med Commun. 2002 May;23(5):447-52.

Gratz S, Dorner J, Fischer U, Behr M, Behe M, Altenvoerde G, Meller J, Grabbe E, Becker W.
18F-FDG hybrid PET in patients with suspected spondylitis.
Eur J Nucl Med. 2002 Apr;29(4):516-24.

Gratz S, Rennen HJ, Boerman OC, Oyen WJ, Mast P, Behr TM, Corstens FH.
99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.
J Nucl Med. 2002 Jul;43(7):918-24.

Wulbrand U, Feldman M, Pfestroff A, Fehman HC, Du J, Hiltunen J, Marquez M, Arnold R, Westlin JE, Nilsson S, Holmberg AR.
A novel somatostatin conjugate with a high affinity to all five somatostatin
receptor subtypes
Cancer. 2002;94(4 Suppl):1293-7

Publikationen im Jahr 2001

Becker W, Behr T.
High dose radioimmunotherapy in relapsed B-cell lymphoma with I-131 rituximab.
Ann Hematol. 2001;80 Suppl 3:B130-1.

Behe M, Du J, Becker W, Behr T, Angerstein C, Marquez M, Hiltunen J, Nilsson S, Holmberg AR.
Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate.
Med Oncol. 2001;18(1):59-64.

Behr TM, Behe M, Jungclas H, Becker W, Sgouros G.
Higher relative biological efficiency of alpha-particles: in vitro veritas, in vivo vanitas.
Europ J Nucl Med. 2001;2:939-940 (letter)

Behr TM, Behe M, Wormann.
Breast cancer and herceptin.
N Engl J Med. 2001; 345(13):995-996 (letter)

Behr TM, Behe MP.
Radioimmunotherapy versus traditional, nontargeted forms of systemic cancer treatment.
Expert Rev Anticancer Ther. 2001 Dec;1(4):501-5.

Behr TM, Gotthardt M, Barth A, Behe M.
Imaging tumors with peptide-based radioligands.
Q J Nucl Med. 2001 Jun;45(2):189-200. Review.

Dünne AA , Jungclas H, Werner J.A.
Intraoperative sentinel node biopsy in patients with squamous cell carcinomas of the head and neck - experiences using a well-type NaI detector for gamma ray spectroscopy
Otorhinolaryngol Pol. 2 (2001) 127-134

Gratz S, Behe M, Boerman OC, Kunze E, Schulz H, Eiffert H, O'Reilly T, Behr TM, Angerstein C, Nebendahl K, Kauer F, Becker W.
(99m)Tc-E-selectin binding peptide for imaging acute osteomyelitis in a novel rat model.
Nucl Med Commun. 2001 Sep;22(9):1003-13.

Gratz S, Rennen HJ, Boerman OC, Oyen WJ, Burma P, Corstens FH.
(99m)Tc-interleukin-8 for imaging acute osteomyelitis.
J Nucl Med. 2001 Aug;42(8):1257-64.

Gratz S, Rennen HJ, Boerman OC, Oyen WJ, Corstens FH.
Rapid imaging of experimental colitis with (99m)Tc-interleukin-8 in rabbits.
J Nucl Med. 2001 Jun;42(6):917-23.

Heufelder AE, Morgenthaler N, Schipper ML, Joba W.
Sodium iodide symporter-based strategies for diagnosis and treatment of thyroidal and nonthyroidal malignancies.
Thyroid. 2001 Sep;11(9):839-47.

Komarov VV, Popova AM, Stureiko IO, Schmidt L, Jungclas H.
Resonant Dissociation of Polyatomic Surface Molecules by Hyperthermal Ions
Rapid Commun. Mass Spectrom. 15 (2001) 1625

Papos M, Pekrun A, Herms JW, Behr TM, Meller J, Rustenbeck HH, Kretzschmar HA, Becker W.
Somatostatin receptor scintigraphy in the management of cerebral malignant ectomesenchymoma: a case report.
Pediatr Radiol. 2001 Mar;31(3):169-72.

Publikationen im Jahr 2000

Alexanova E.D. and others
Coulomb excitation of polyatomic organic molecules in their slow surface sliding.
Phys Bull 2000; 4:5.

Bangard M, Behe M, Guhlke S, Otte R, Bender H, Maecke HR, Biersack HJ.
Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
Eur J Nucl Med. 2000 Jun;27(6):628-37.

Behr TM, Behe M, Lohr M, Sgouros G, Angerstein C, Wehrmann E, Nebendahl K, Becker W.
Therapeutic advantages of Auger electron- over beta-emitting radiometals or radioiodine when conjugated to internalizing antibodies.
Eur J Nucl Med. 2000 Jul;27(7):753-65.

Behr TM, Blumenthal RD, Memtsoudis S, Sharkey RM, Gratz S, Becker W, Goldenberg DM.
Cure of metastatic human colonic cancer in mice with radiolabeled monoclonal antibody fragments.
Clin Cancer Res. 2000 Dec;6(12):4900-7.

Benamer TS, Patterson J, Grosset DG, Booij J, de Bruin K, van Royen E, Speelman JD, Horstink MH, Sips HJ, Dierckx RA, Versijpt J, Decoo D, Van Der Linden C, Hadley DM, Doder M, Lees AJ, Costa DC, Gacinovic S, Oertel WH, Pogarell O, Hoeffken H, Joseph K, Tatsch K, Schwarz J, Ries V.
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group.
Mov Disord. 2000 May;15(3):503-10.

Borsilov V.A. and others
Coulomb excitation of diatomic molecules slowly sliding over cristal surfaces.
Phys Bull 2000; 3:9.

Froidevaux S, Heppeler A, Eberle AN, Meier AM, Hausler M, Beglinger C, Behe M, Powell P, Macke HR.
Preclinical comparison in AR4-2J tumor-bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-somatostatin analogs for tumor diagnosis and internal radiotherapy.
Endocrinology. 2000 Sep;141(9):3304-12.

Gotthardt M, Brandt D, Kuni H, Joseph K.
Venous bypass after deep venous thrombosis visible on an early-phase bone scan.
Clin Nucl Med. 2000 Apr;25(4):291-2.

Gotthardt M, Welcke U, Brandt D, Tontsch D, Barth PJ, Schaefer J, Hoeffken H, Joseph K.
The role of bone scintigraphy in patients with Erdheim-Chester disease.
Clin Nucl Med. 2000 Jun;25(6):414-20.

Gotthardt M, Welcke U, Fritsch HW, Simon B, Fischer M, Brandt D, Hoffken H, Joseph K.
Huge necrotic liver metastases in advanced pancreatic carcinoma visualized on bone scans.
Clin Nucl Med. 2000 Mar;25(3):210-2.

Gratz S, Becker W.
[Nuclear medicine study potentials in diseases of the skeletal system]
Radiologe. 2000 Oct;40(10):953-62. Review. German.

Gratz S, Dorner J, Oestmann JW, Opitz M, Behr T, Meller J, Grabbe E, Becker W.
67Ga-citrate and 99Tcm-MDP for estimating the severity of vertebral osteomyelitis.
Nucl Med Commun. 2000 Jan;21(1):111-20.

Gratz S, Gobel D, Becker W.
[Radiosynoviorthesis in inflammatory joint diseases]
Orthopade. 2000 Feb;29(2):164-70. Review. German.

Gratz S, Raddatz D, Hagenah G, Behr T, Behe M, Becker W.
99mTC-labelled antigranulocyte monoclonal antibody FAB' fragments versus echocardiography in the diagnosis of subacute infective endocarditis.
Int J Cardiol. 2000 Aug;75(1):75-84.

Gratz S. and others
Bedeutung der SPECT bei der Knochenszintigraphie.
Der Nuklearmediziner 2000; 2:105-15

Gratz S. and others
Ergebnisse zur Immunszintigraphie der Osteomyelitis (LeukoScan).
Der Nuklearmediziner 2000; 2:117-32

Komarov VV, Popova AM, Stureiko IO, Jungclas H.
Fragmentation of Polyatomic Organic Molecules on the Surface under the Action of low Energy Ions
Phys. Bull. (Moscow State Univ. ISSN 0027/1349), Allerton Press Inc. New York, 55 no. 4 (2000) 5

Meller J, Altenvoerde G, Munzel U, Jauho A, Behe M, Gratz S, Luig H, Becker W.
Fever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET.
Eur J Nucl Med. 2000 Nov;27(11):1617-25.

Meller J, Wisheu S, Munzel U, Behe M, Gratz S, Becker W.
Radioiodine therapy for Plummer's disease based on the thyroid uptake of technetium-99m pertechnetate.
Eur J Nucl Med. 2000 Sep;27(9):1286-91.

Wieghaus A, Schmidt L, Popova AM, Komarov VV, Jungclas H.
Grazing incidence surface-induced dissociation of protonated peptides generated by matrix-assisted laser desorption/ionization.
Rapid Commun Mass Spectrom. 2000;14(18):1654-61.

Wilke A, Wolf U, Gotthardt M.
[Imaging of blocks in the spine with bone scintigraphy (SPECT)]
Biomed Tech (Berl). 2000 Jul-Aug;45(7-8):206-10. German.

Publikationen im Jahr 1999

Alexanova ED, Komarov VV, Popova AM, Jungclas H.
Coulomb excitation of Polyatomic Organic Molecules in their Slow Surface Sliding
Phys. Bull. (Moscow State Univ. ISSN 0027/1349), Allerton Press Inc. New York, 54 no. 4 (1999) 64

Behr TM, Becker W.
[Increased blood CEA level as initial manifestation of medullary thyroid carcinoma]
Dtsch Med Wochenschr. 1999 Mar 12;124(10):303-4. German.

Behr TM, Becker W.
Metabolic and receptor imaging of metastatic medullary thyroid cancer: does anti-CEA and somatostatin-receptor scintigraphy allow for prognostic predictions?
Eur J Nucl Med. 1999 Jan;26(1):70-1.

Behr TM, Behe M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Clin Cancer Res. 1999 Oct;5(10 Suppl):3124s-3138s.

Behr TM, Behe M, Becker W.
Diagnostic applications of radiolabeled peptides in nuclear endocrinology.
Q J Nucl Med. 1999 Sep;43(3):268-80. Review.

Behr TM, Behe M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
Cancer Res. 1999 Jun 1;59(11):2635-43.

Behr TM, Boerman OC.
13th Meeting of the International Research Group on Immunoscintigraphy and Immunotherapy (IRIST). 7-8 May 1999, Gottingen, Germany.
Eur J Nucl Med. 1999 Aug;26(8):950-2.

Behr TM, Jenner N, Behe M, Angerstein C, Gratz S, Raue F, Becker W.
Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
J Nucl Med. 1999 Jun;40(6):1029-44.

Behr TM, Memtsoudis S, Vougioukas V, Liersch T, Gratz S, Schmidt F, Lorf T, Post S, Wormann B, Hiddemann W, Ringe B, Becker W.
Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
Anticancer Res. 1999 Jul-Aug;19(4A):2427-32.

Behr TM, Salib AL, Liersch T, Behe M, Angerstein C, Blumenthal RD, Fayyazi A, Sharkey RM, Ringe B, Becker H, Wormann B, Hiddemann W, Goldenberg DM, Becker W.
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.
Clin Cancer Res. 1999 Oct;5(10 Suppl):3232s-3242s.

Behr TM, Sgouros G, Stabin MG, Behe M, Angerstein C, Blumenthal RD, Apostolidis C, Molinet R, Sharkey RM, Koch L, Goldenberg DM, Becker W.
Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
Clin Cancer Res. 1999 Oct;5(10 Suppl):3031s-3043s.

Behr TM, Wormann B, Gramatzki M, Riggert J, Gratz S, Behe M, Griesinger F, Sharkey RM, Kolb HJ, Hiddemann W, Goldenberg DM, Becker W.
Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.
Clin Cancer Res. 1999 Oct;5(10 Suppl):3304s-3314s.

Kunz K, Anastasiadis SH, Stamm M, Schurrat T, Rauch F
The segregation of poly(styrene-b-isoprene) diblock copolymers to the surface of a polystyrene melt: the effect of the ratio of block lengths.
Eur Phys J B 7 (3): 411-419 Feb 1999

Gotthardt M. and others
Case of a persistent segmental perfusion defect in an intermediate probability lung scan.
Clin Nucl Med 1999; 24:603-5.

Gratz S, Gobel D, Behr TM, Herrmann A, Becker W.
Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis.
J Rheumatol. 1999 Jun;26(6):1242-9.

Heppeler A, Froidevaux S, Mäcke HR, Jermann E, Béhé M, Powell P, Hennig M.
Radiometal-labelled macrocyclic chelator-derivatised somatostatin analogue with superb tumour-targeting properties and potential for receptor-mediated internal radiotherapy.
Chem Eur J. 1999; 5:1974-81.

Jungclas H, Wieghaus A, Schmidt L, Popova AM, Komarov VV
Fragmentation of Molecules Sliding along Surfaces in the Speed Range above Thermal and below Bohr Velocity
J. Am. Soc. Mass Spectrom. 10 (1999) 471

Otte A, Herrmann R, Heppeler A, Behe M, Jermann E, Powell P, Maecke HR, Muller J.
Yttrium-90 DOTATOC: first clinical results. Eur J Nucl Med. 1999 Nov;26(11):1439-47.

Rother A, Kniess T, Pütz M, Jungclas H, Spies H.
Nicotinamide-Substituted Complexes as Redox Markers: 2. Synthesis of a 99Tc-Dihydropyridine Mixed-Ligand Complex and Investigation of its Stability in Tissue Homogenates
J. Labelled Cpd. Radiopharm. 42 (1999) 673

Rother A. and others
Nicotinamide-substituted complexes as redox markers: 2. Synthesis of a 99-Tc-Dihydropyridine mixed-ligand complex and investigation of its stability in tissue homogenates.
J Labelled Cpd Radiopharm 1999; 42:673.

Wieghaus A, Schmidt L, Popova AM, Komarov VV, Jungclas H.
Fragmentation of Polyatomic Molecules by Grazing Incidence Surface-induced Dissociation (GI-SID)
J. Mass Spectrom. 34 (1999) 1178

Publikationen im Jahr 1998

Behr TM, Goldenberg DM, Becker W.
Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: present status, future prospects and limitations.
Eur J Nucl Med. 1998 Feb;25(2):201-12. Review.

Behr TM, Jenner N, Radetzky S, Behe M, Gratz S, Yucekent S, Raue F, Becker W.
Targeting of cholecystokinin-B/gastrin receptors in vivo: preclinical and initial clinical evaluation of the diagnostic and therapeutic potential of radiolabelled gastrin.
Eur J Nucl Med. 1998 Apr;25(4):424-30.

Behr TM, Memtsoudis S, Sharkey RM, Blumenthal RD, Dunn RM, Gratz S, Wieland E, Nebendahl K, Schmidberger H, Goldenberg DM, Becker W.
Experimental studies on the role of antibody fragments in cancer radio-immunotherapy: Influence of radiation dose and dose rate on toxicity and anti-tumor efficacy.
Int J Cancer. 1998 Aug 31;77(5):787-95.

Behr TM, Sgouros G, Vougiokas V, Memtsoudis S, Gratz S, Schmidberger H, Blumenthal RD, Goldenberg DM, Becker W.
Therapeutic efficacy and dose-limiting toxicity of Auger-electron vs. beta emitters in radioimmunotherapy with internalizing antibodies: evaluation of 125I- vs. 131I-labeled CO17-1A in a human colorectal cancer model.
Int J Cancer. 1998 May 29;76(5):738-48.

Borsilov VA, Satekin VV, Komarov VV, Popova AM, Jungclas H.
Coulomb excitation of Diatomic Molecules Slowly Sliding over Cristal Surfaces
Phys. Bull. (Moscow State Univ. ISSN 0027/1349), Allerton Press Inc. New York, 53 no. 3 (1998)

De Jong M, Bakker WH, Breeman WA, Bernard BF, Hofland LJ, Visser TJ, Srinivasan A, Schmidt M, Behe M, Macke HR, Krenning EP.
Pre-clinical comparison of [DTPA0] octreotide, [DTPA0,Tyr3] octreotide and [DOTA0,Tyr3] octreotide as carriers for somatostatin receptor-targeted scintigraphy and radionuclide therapy.
Int J Cancer 1998; 75:406-11.

Göbel D. and others
Kann die sonographische Synovialisbeurteilung der Artikulosynovitis bei chronischer Polyarthritis zur Therapieentscheidung und Überwachung beitragen?
Orthopädische Praxis 1998; 34:547-52

Gratz S, Behr T, Herrmann A, Dresing K, Tarditi L, Franceschini R, Rhodes B, Sturmer KM, Becker W.
Intraindividual comparison of 99mTc-labelled anti-SSEA-1 antigranulocyte antibody and 99mTc-HMPAO labelled white blood cells for the imaging of infection.
Eur J Nucl Med. 1998 Apr;25(4):386-93.

Gratz S, Behr TM, Herrmann A, Meller J, Conrad M, Zappel H, Becker W.
Immunoscintigraphy (BW 250/183) in neonates and infants with fever of unknown origin.
Nucl Med Commun. 1998 Nov;19(11):1037-45.

Gratz S. and others
Radionuclide arthrography in suspected ratator cuff rupture.
Nucl Med 1998; 37:372-78.

Herrmann A, Gratz S, Behr T, Meller J, Becker W.
[Suppressibility of thyroid autonomy in endogenous and additional exogenous TSH suppression in patients with thyroid autonomy]
Nuklearmedizin. 1998 Jan;37(1):18-22. German.

Jungclas H, Komarov VV, Popova AM, Schmidt L.
Role of Internal Molecular Structures in Grazing Surface Induced Dissociation
Eur. Phys. J. D 1 (1998) 193

Meller J, Conrad M, Behr T, Gratz S, Becker W.
[Differentiated thyroid gland carcinoma in children and adolescents]
Klin Padiatr. 1998 Sep-Oct;210(5):373-8. Review. German.

Meller J, Ivancevic V, Conrad M, Gratz S, Munz DL, Becker W.
Clinical value of immunoscintigraphy in patients with fever of unknown origin.
J Nucl Med. 1998 Jul;39(7):1248-53.

Reddy N, Ong GL, Behr TM, Sharkey RM, Goldenberg DM, Mattes MJ.
Rapid blood clearance of mouse IgG2a and human IgG1 in many nude and nu/+ mouse strains is due to low IgG2a serum concentrations.
Cancer Immunol Immunother. 1998 Mar;46(1):25-33.

Zuletzt aktualisiert: 01.04.2014 · Tino Schurrat

Fb. 20 - Medizin

Klinik für Nuklearmedizin, Baldingerstraße, D-35043 Marburg
Tel. +49 6421/58-62813; -62815, Fax +49 6421/58-67025, E-Mail: nukmed@med.uni-marburg.de

URL dieser Seite: https://www.uni-marburg.de/fb20/nuklearmed/publ

Impressum | Datenschutz